Methods of administering apo b-secretion/mtp inhibitors

Details Methods of administering apo b-secretion/mtp inhibitors Methods of administering apo b-secretion/mtp inhibitors

A - Human Necessities

61

K

A61K 31/47 (2006.01) A61K 31/00 (2006.01) A61K 31/437 (2006.01) A61K 31/4468 (2006.01) A61K 31/454 (2006.01) A61K 31/4709 (2006.01) A61K 31/472 (2006.01) A61K 31/4725 (2006.01) A61K 31/4745 (2006.01) A61K 31/495 (2006.01) A61K 31/4985 (2006.01) A61K 31/53 (2006.01) A61K 31/535 (2006.01) A61K 31/5377 (2006.01) A61K 31/54 (2006.01) A61P 1/18 (2006.01) A61P 3/06 (2006.01) A61P 3/10 (2006.01) A61P 9/10 (2006.01)

Patent

CA 2325201

Disclosed is a medicine for reducing total serum cholesterol and LDL-cholesterol, which comprises (a) a pharmaceutically acceptable carrier, vehicle or diluent and (b) an effective amount of an apolipoprotein B-secretion (apo B)/microsomal triglyceride transfer protein (MTP) inhibitor and which is to be taken by a subject in need of such reduction prior to or during a somnolent period of the subject being treated.

Affiliated with

Also associated with

Rating

Methods of administering apo b-secretion/mtp inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods of administering apo b-secretion/mtp inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of administering apo b-secretion/mtp inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1928845